Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Tolfenamic Acid Derivatives: A New Class of Transcriptional Modulators with Potential Therapeutic Applications for Alzheimer’s Disease and Related Disorders

International Journal of Molecular Sciences(2023)10.3390/ijms242015216Source: DataRank Database

Tolfenamic Acid Derivatives: A New Class of Transcriptional Modulators with Potential Therapeutic Applications for Alzheimer’s Disease and Related Disorders is a research paper published in International Journal of Molecular Sciences (2023). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.57)OA: goldTopics (55)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Karim E. Shalaby ORCID,Syed Waseem Bihaqi ORCID,Bothaina H. Alansi,Benjamin Barlock ORCID,Keykavous Parang ORCID

Live enrichment

PubMed:37894896 PMC:PMC10607430 OpenAlex:https://openalex.org/W4387670784

the National Institutes of Health

Grant: R36AG062868

the National Institutes of Health

Grant: IGP5

National Institutes of Health

Grant: 5R36AG062868-02

Novel Analogs for Tauopathies and Their Mode of Action

FWCI

0.57

Citation Percentile

0.7%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/1422-0067/24/20/15216/pdf?version=1697428689

publisherhttps://www.mdpi.com/1422-0067/24/20/15216/pdf?version=1697428689

publisherhttps://www.mdpi.com/1422-0067/24/20/15216/pdf

journalhttps://doi.org/10.3390/ijms242015216

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37894896

Fields of Study

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsTryptophan and brain disordersMiceAnimalsAlzheimer DiseaseMice, TransgenicAmyloid beta-Protein Precursorortho-Aminobenzoatestau ProteinsAmyloid beta-Peptides

MeSH Terms

Alzheimer DiseaseAnimalsMice, TransgenicAmyloid beta-PeptidesAmyloid beta-Protein Precursortau ProteinsMiceortho-Aminobenzoates

Keywords

Drug discoveryComputational biologyAlzheimer's diseasePharmacophoreAmyloid precursor proteinDYRK1ADiseaseProteomeBiologyGeneBioinformaticsNeuroscienceMedicineBiochemistryDrug designAlzheimer’s diseaseSmall moleculesSp1Drug DevelopmentTolfenamic AcidAmyloid beta-PeptidesPharmaceutics and Drug DesignMice, Transgenictau ProteinsTherapeuticsAlzheimerâ€™s diseaseArticleMiceAmyloid beta-Protein PrecursorAlzheimer DiseaseAnimalsOther Pharmacy and Pharmaceutical Sciencesortho-AminobenzoatesNervous System DiseasesMedical GeneticsMedicinal and Pharmaceutical Chemistry

Sustainable Development Goals

SDG 0: Good health and well-being

Tolfenamic Acid Derivatives: A New Class of Transcriptional Modulators with Potential Therapeutic Applications for Alzheimer’s Disease and Related Disorders

FAIR Checklist

Authors (9)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)